64
Participants
Start Date
May 31, 2014
Primary Completion Date
February 15, 2018
Study Completion Date
March 9, 2018
IDN-6556
Placebo
Placebo control
Columbia University Medical Center, New York
University of Pennsylvania Milton Hershey Hospital, Philadelphia
Temple University Hospital, Philadelphia
Albert Einstein Medical Center, Philadelphia
Georgetown University Hospital, Washington D.C.
Johns Hopkins Sibley Memorial Hospital, Washington D.C.
John Hopkins Hospital, Baltimore
Bon Secours St. Mary's Hospital of Richmond, Richmond
McGuire DVAMC, Richmond
Bon Secours Mary Immaculate Hospital, Newport News
Piedmont Atlanta Hospital, Atlanta
University of Florida, Gainesville
University of Miami, Miami
University of Louisville, Louisville
University of Cincinnati Physicians Company, Cincinnati
Indiana University, Indianapolis
Henery Ford Health System, Detroit
Rush University Medical Center, Chicago
University of Chicago Medicine, Chicago
Saint Louis University, St Louis
University of Kansas Medical Center, Kansas City
Tulane Health Science Center, New Orleans
Ochsner Clinic, New Orleans
Baylor All Saints Medical Center, Fort Worth
Liver Associates of Texas, PA, Houston
University of Texas Health Science Center at Houston, Houston
VAMC/Baylor College of Medicine, Houston
University of Utah, Salt Lake City
UCLA Pfleger Liver Institute, Los Angeles
Scripps Clinic, La Jolla
Southern California Research Center, Coronado
Loma Linda University Medical Center, Loma Linda
University of Washington Harborview Medical Center, Seattle
Beth Israel Deaconess Medical Center, Boston
Rutgers New Jersey Medical School, Newark
Lead Sponsor
Conatus Pharmaceuticals Inc.
INDUSTRY